Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

Dutch Bros Stock Is Way Too Expensive Given Its Negative Catalysts

By Larry Ramer, InvestorPlace Contributor

Dutch Bros is facing multiple challenges, and BROS stock is trading at a very high valuation.

Steep Macro Challenges Make Chegg Stock Unappealing

By Larry Ramer, InvestorPlace Contributor

Chegg's tough macro issues and anemic growth outlook, along with the high valuation of CHGG stock, make it unattractive.

Rivian Stock Could Reach $200 in Just a Few Months

By Larry Ramer, InvestorPlace Contributor

Rivian's backing from Amazon and a number of Wall Street's largest banks should lift RIVN stock over the medium-term.

QuantumScape’s Risk Has Dropped, But It Remains High

By Larry Ramer, InvestorPlace Contributor

With QuantumScape continuing to face tough competition and significant uncertainty, QS stock continues to be very risky.

Amid More Evidence of Tough Competition, Teladoc Stock Remains a Sell

By Larry Ramer, InvestorPlace Contributor

Teladoc's slowing growth and increased spending indicates that its competition is increasingly tough, making TDOC stock a sell.

A Lack of Buzz Makes Lucid’s Valuation All the More Surprising

By Larry Ramer, InvestorPlace Contributor

Lucid is not generating the kind of publicity nor order total its needs to justify the gigantic valuation of LCID stock.

3 Cheap Growth Stocks to Buy for December

By Larry Ramer, InvestorPlace Contributor

Spurred by their low valuations and powerful growth catalysts, these cheap growth stocks are well-positioned to rally.

EVgo Stock Is Vastly Undervalued Given Its Partnerships

By Larry Ramer, InvestorPlace Contributor

Given the strong partnerships of EVgo and the very low valuation of EVGO stock, the shares are worth buying for long-term investors.

Coupang Stock Is a Great Buy Even If It’s Not the Next Amazon

By Larry Ramer, InvestorPlace Contributor

The parallels between the e-commerce giants are striking, but CPNG stock could surge even if the company fails to boost profits like Amazon.

Novavax Is a Buy Based on Its Outlook, But Not for the Long Haul

By Larry Ramer, InvestorPlace Contributor

As the Novavax vaccine becomes approved by more and more countries, NVAX stock will likely climb in the near-to-medium term.

Load More